Literature DB >> 30833213

Frailty is associated with myosteatosis in obese patients with colorectal cancer.

Nilian Carla Souza1, Maria Cristina Gonzalez2, Renata Brum Martucci3, Viviane Dias Rodrigues4, Nivaldo Barroso de Pinho5, Antonio Ponce de Leon6, Carla Maria Avesani7.   

Abstract

BACKGROUND & AIMS: We aimed to explore the determinants of muscle fat infiltration and to investigate whether myosteatosis, assessed as muscle fat infiltration percentage (%MFI) and muscle attenuation from computed tomography (CT), is associated with frailty in a group of patients with colorectal cancer (CRC).
METHODS: Cross sectional study including CRC patients. CT scan of the third lumbar vertebra was used to quantify body composition and the degree of %MFI (reported as percentage of fat within muscle area). Frailty was defined by Fried et al. (2001) as the presence of more than 3 criteria: unintentional weight loss, self-reported exhaustion, weakness (low handgrip strength), slow walking speed (gait speed) and low physical activity. Obesity was defined according to sex-and-age-specific body fat percentage (%BF) cutoff.
RESULTS: A sample of 184 patients (age 60 ± 11 years; 58% men; 29% of patients with frailty) was studied. The sample was divided according to tertiles of MFI% (1st tertile 0 to 2.89%, n = 60; 2nd tertile ≥ 3.9-8.19%, n = 64; 3rd tertile ≥ 8.2-26%, n = 60). Age, females, body mass index, %BF, subcutaneous and visceral adipose tissue and the proportion of patients with frailty were significantly higher in the 3rd %MFI tertile. Phase angle and muscle attenuation were significantly lower in the 3rd %MFI tertile. The determinants of %MFI (r2 = 0.49), which was log transformed due to its normal distribution, were %BF (β = 0.54; eβ = 1.72; 95% CI: 0.032 to 0.051; P < 0.01), age (β = 0.34; eβ = 1.40; 95% CI: 0.016 to 0.032; P < 0.01) and gait speed (β = -0.12; eβ = 0.87; 95% CI: -0.84 to -0.001; P = 0.049). In addition, in obese patients (n = 74) presenting 4 or 5 frailty criteria increased the chance of having higher %MFI and lower muscle attenuation, after adjustment for sex, age and comorbidities when compared to none or 1 criteria.
CONCLUSIONS: In a sample of CRC patients, %BF and gait speed were the determinants of %MFI. In addition, markers of myostetatosis were associated with frailty in the obese patients.
Copyright © 2019 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Entities:  

Keywords:  Cancer patients; Frailty; Myosteatosis; Obesity

Year:  2019        PMID: 30833213     DOI: 10.1016/j.clnu.2019.02.026

Source DB:  PubMed          Journal:  Clin Nutr        ISSN: 0261-5614            Impact factor:   7.324


  5 in total

Review 1.  Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis.

Authors:  Shaofang Feng; Huiwen Mu; Rong Hou; Yunxin Liu; Jianjun Zou; Zheng Zhao; Yubing Zhu
Journal:  Int J Clin Oncol       Date:  2022-05-23       Impact factor: 3.402

2.  Associations of Trunk Muscle Mass and Muscle Quality Indicators with Self-Reported Dysphagia in Older Inpatients.

Authors:  Xiaofan Jing; Ming Yang; Yuan Liu; Yan Wang; Jingjing Li; Wen Hu
Journal:  Dysphagia       Date:  2022-07-04       Impact factor: 3.438

3.  Relationship between sarcopenia/myosteatosis and frailty in hospitalized patients with cirrhosis: a sex-stratified analysis.

Authors:  Hongjuan Feng; Xiaoyu Wang; Lihong Mao; Zihan Yu; Binxin Cui; Lin Lin; Yangyang Hui; Xingliang Zhao; Xin Xu; Xiaofei Fan; Bangmao Wang; Qingxiang Yu; Kui Jiang; Chao Sun
Journal:  Ther Adv Chronic Dis       Date:  2021-07-27       Impact factor: 5.091

4.  CT-Based Sarcopenic Nomogram for Predicting Progressive Disease in Advanced Non-Small-Cell Lung Cancer.

Authors:  Xiaoping Yi; Qiurong Chen; Jingying Yang; Dengke Jiang; Liping Zhu; Haipeng Liu; Peipei Pang; Feiyue Zeng; Changyong Chen; Guanghui Gong; Hongling Yin; Bin Li; Bihong T Chen
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

5.  Low skeletal muscle radiodensity and neutrophil-to-lymphocyte ratio as predictors of poor outcome in patients with COVID-19.

Authors:  Daniela M H Padilha; Maria C S Mendes; Fabiana Lascala; Marina N Silveira; Lara Pozzuto; Larissa A O Santos; Lívia D Guerra; Rafaella C L Moreira; Sandra R Branbilla; Ademar D C Junior; Mateus B O Duarte; Maria L Moretti; José B C Carvalheira
Journal:  Sci Rep       Date:  2022-09-20       Impact factor: 4.996

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.